Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherary


DEDE D. S. , GUMUSKAYA B., Guler G. , ONAT D. , ALTUNDAG K., ÖZIŞIK Y. Y.

JOURNAL OF BUON, cilt.18, ss.366-371, 2013 (SCI İndekslerine Giren Dergi) identifier identifier

  • Cilt numarası: 18 Konu: 2
  • Basım Tarihi: 2013
  • Dergi Adı: JOURNAL OF BUON
  • Sayfa Sayıları: ss.366-371

Özet

Purpose: The aim of this study was to assess the changes in biologic markers of breast cancer ER, PR, HER 2 and Ki-67 in locally advanced breast cancer patients after neoadjuvant chemotherapy.